http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0390024-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7115ef17a0cce55f36229865e31ea6a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 1990-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83bc7ec771a02bf09361dfcc0a69d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e62f3b4d4188d4bdcd39ed64ed80db8
publicationDate 1991-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0390024-A
titleOfInvention Medicinal composition containing 5-methyl-isoxazole-4-carboxylic acid anilide or 2-hydroxyethylidene-cyanoacetic acid anilide for treating eye disease
abstract PURPOSE: To obtain the subject medicinal composition for treating eye diseases caused by immunological factors. n CONSTITUTION: This medicinal composition for treating eye diseases caused by immunological factors contains a compound of formula I (R 1 to R 3 are each an alkyl, an alkoxy, an alkylthio, a halogen, nitro, cyano, an alkoxycarbonyl, or R 1 and R 2 are each H, and R 3 is an alkyl except methyl, phenyl, etc.) or a compound of formula II (R 1 to R 3 are each Cl, F, Br, an alkyl, an alkoxy, an alkylthio, nitro, cyano, an alkoxycarbonyl, etc.) and a pharmaceutically permissible carrier. It is preferable that the active compound is administered daily at a level of 0.001-30mg/kg body weight. n COPYRIGHT: (C)1991,JPO
priorityDate 1989-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53844808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416094201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421222800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID850263

Total number of triples: 34.